TNX-4800
Prevention of Lyme Disease
Phase 1Phase 2 Planned
Key Facts
About Tonix Pharmaceuticals
Tonix Pharmaceuticals is a clinical-stage biotech focused on addressing difficult-to-treat conditions across CNS, immunology, infectious diseases, and rare diseases. Its strategy leverages multiple technology platforms, including a sublingual delivery system, a live virus vaccine platform, and monoclonal antibody development, to advance a broad pipeline. Key near-term catalysts include Phase 2 data for TNX-102 SL in Acute Stress Disorder and the progression of its Phase 2-ready programs in organ transplant rejection and Prader-Willi Syndrome.
View full company profile